Evidence map›Paper›PMID 34239732›Full record

ArticleProstate cancer2021

Implications of Regionalizing Care in the Developing World: Impact of Distance to Referral Center on Compliance to Biopsy Recommendations in a Brazilian Prostate Cancer Screening Cohort.

Alexis R Freedland, Roberto L Muller, Cathrine Hoyo, Elizabeth L Turner, Patricia G Moorman, Eliney F Faria, Gustavo F Carvalhal, Rodolfo B Reis, Edmundo C Mauad, Andre L Carvalho and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Prostate cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Alexis R FreedlandDepartment of Epidemiology, UCI School of Medicine, University of California, Irvine, CA, USA.ORCID https://orcid.org/0000-0001-5277-5113
Roberto L MullerDivision of Urology, Center of Oncologic Research, Florianopolis, Santa Catarina, Brazil.ORCID https://orcid.org/0000-0001-6434-8231
Cathrine HoyoDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, USA.ORCID https://orcid.org/0000-0002-2466-8617
Elizabeth L TurnerGlobal Health Institute, Duke University, Durham, NC, USA.
Patricia G MoormanDepartment of Community and Family Medicine, Cancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA.ORCID https://orcid.org/0000-0002-2978-6495
Eliney F FariaDivision of Urologic Oncology and Laparoscopy, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-8297-3417
Gustavo F CarvalhalResearch Support Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-4401-0791
Rodolfo B ReisDivision of Urology, Ribeirao Preto Medical School of Sao Paulo University (USP), Ribeirao Preto, São Paulo, Brazil.ORCID https://orcid.org/0000-0003-0328-1840
Edmundo C MauadDepartment of Preventative Medicine, Barretos Cancer Hospital and Pio XII Foundation, Barretos, São Paulo, Brazil.
Andre L CarvalhoResearch Support Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Stephen J FreedlandDivision of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-8104-6419
Hospital de Câncer de Barretos · BRCedars-Sinai Medical Center · USCentro de Pesquisas Oncológicas · BRDuke Cancer InstituteDuke University · USNorth Carolina State University · USUniversity of California, Irvine · US

Funding

Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Sue Fenton · 2015 to 2026
$18.3M
NIEHS NIH HHS P30 ES025128
6 · The paper itself

Abstract

Given growing specialization in medical care, optimal care may require regionalization, which may create access barriers. We tested this within a large prostate cancer (PC) screening program in Brazil. In 2004-2007, Barretos Cancer Hospital prospectively screened men for PC throughout rural Brazil. Men with abnormal screen were referred for follow-up and possible biopsy. We tested the link between distance from screening site to Barretos Cancer Hospital and risk of noncompliance with showing up for biopsy, PC on biopsy and, among those with PC, PC grade using crude and multivariable logistic regression analysis. Among 10,467 men undergoing initial screen, median distance was 257 km (IQR: 135-718 km). On crude and multivariable analyses, farther distance was significantly linked with biopsy noncompliance (OR/100 km: 0.83,

Identifiers

PMID34239732
PMCPMC8241493
OpenAlexW3173921172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.